NextCell Pharma AB (OSTO:NXTCL) Days Payable : 84.48 (As of Feb. 2024)

View and export this data going back to 2017. Start your Free Trial

What is NextCell Pharma AB Days Payable?

NextCell Pharma AB's average Accounts Payable for the three months ended in Feb. 2024 was kr2.55 Mil. NextCell Pharma AB's Cost of Goods Sold for the three months ended in Feb. 2024 was kr2.76 Mil. Hence, NextCell Pharma AB's Days Payable for the three months ended in Feb. 2024 was 84.48.

The historical rank and industry rank for NextCell Pharma AB's Days Payable or its related term are showing as below:

OSTO:NXTCL' s Days Payable Range Over the Past 10 Years
Min: 17.41 Med: 31.63 Max: 291.31
Current: 83.57

During the past 9 years, NextCell Pharma AB's highest Days Payable was 291.31. The lowest was 17.41. And the median was 31.63.

OSTO:NXTCL's Days Payable is ranked worse than
62.57% of 724 companies
in the Biotechnology industry
Industry Median: 150.695 vs OSTO:NXTCL: 83.57

NextCell Pharma AB's Days Payable increased from Feb. 2023 (79.51) to Feb. 2024 (84.48). It may suggest that NextCell Pharma AB delayed paying its suppliers.

NextCell Pharma AB Days Payable Historical Data

The historical data trend for NextCell Pharma AB's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NextCell Pharma AB Days Payable Chart

NextCell Pharma AB Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Days Payable

Get a 7-Day Free Trial

30.60

24.88

17.41

67.05

46.73

NextCell Pharma AB Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Days Payable	Get a 7-Day Free Trial															79.51	106.17	65.52	53.75	84.48

Competitive Comparison of NextCell Pharma AB's Days Payable

For the Biotechnology subindustry, NextCell Pharma AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NextCell Pharma AB's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NextCell Pharma AB's Days Payable distribution charts can be found below:

* The bar in red indicates where NextCell Pharma AB's Days Payable falls into.

NextCell Pharma AB Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

NextCell Pharma AB's Days Payable for the fiscal year that ended in Aug. 2023 is calculated as

	Days Payable (A: Aug. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Aug. 2022 )	+	Accounts Payable (A: Aug. 2023 ))	/	count )	/	Cost of Goods Sold (A: Aug. 2023 )	*	Days in Period
=	( (1.924	+	0.892)	/	2 )	/	10.998	*	365
=	1.408					/	10.998	*	365
=	46.73

NextCell Pharma AB's Days Payable for the quarter that ended in Feb. 2024 is calculated as:

	Days Payable (Q: Feb. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Nov. 2023 )	+	Accounts Payable (Q: Feb. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Feb. 2024 )	*	Days in Period
=	( (2.25	+	2.855)	/	2 )	/	2.757	*	365 / 4
=	2.5525					/	2.757	*	365 / 4
=	84.48

NextCell Pharma AB Days Payable Related Terms

Thank you for viewing the detailed overview of NextCell Pharma AB's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

NextCell Pharma AB (OSTO:NXTCL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NextCell Pharma AB (OSTO:NXTCL) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

65G:Germany

Address

Karolinska Institutet Science Park, Halsovagen 7, Huddinge, SWE, 14157

Website

http://www.nextcellpharma.com

NextCell Pharma AB is a healthcare services provider. The company is engaged in the research of stem cell and is developing the candidate drug ProTrans for the treatment of diabetes and immunosuppression in kidney transplants.

NextCell Pharma AB (OSTO:NXTCL) Headlines

No Headlines